Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mei-Juan Tu

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Acta Pharmaceutica Sinica. B|January 30, 2020
Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeuticsWanrong Yi, Mei-Juan Tu, Zhenzhen Liu, et al.
Biochemical Pharmacology|December 28, 2020
Single bioengineered ncRNA molecule for dual-targeting toward the control of non-small cell lung cancer patient-derived xenograft tumor growthHannah Petrek, Pui Yan Ho, Neelu Batra, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|November 11, 2015
[Establishment of MDCK cell models expressing human MATE1 or co-expressing with human OCT1 or OCT2]Hong-mei Lei, Si-yuan Sun, Li-ping Li, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
The Precise Basecalling of Short-Read Nanopore SequencingZiyuan Wang, Mei-Juan Tu, Chengcheng Song, et al.
Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences|May 1, 2014
[In vitro interaction of deferiprone with cellular membrane transporters of hOCTs and hOAT1]Si-si Kong, Mei-juan Tu, Xi Yang, et al.
International Journal of Pharmaceutics|June 13, 2018
Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivoQian-Yu Zhang, Pui Yan Ho, Mei-Juan Tu, et al.
Molecular Therapy. Nucleic Acids|February 13, 2019
Bioengineered Let-7c Inhibits Orthotopic Hepatocellular Carcinoma and Improves Overall Survival with Minimal ImmunogenicityJoseph L Jilek, Qian-Yu Zhang, Mei-Juan Tu, et al.
Molecular Pharmacology|October 14, 2020
MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and GlycolysisMei-Juan Tu, Zhijian Duan, Zhenzhen Liu, et al.
Acta Pharmaceutica Sinica. B|October 6, 2023
Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancerYixin Chen, Mei-Juan Tu, Fangwei Han, et al.
Biochemical Pharmacology|November 1, 2015
Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growthYong Zhao, Mei-Juan Tu, Yi-Feng Yu, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Acta Pharmaceutica Sinica. B|January 30, 2020
Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeuticsWanrong Yi, Mei-Juan Tu, Zhenzhen Liu, et al.
Biochemical Pharmacology|December 28, 2020
Single bioengineered ncRNA molecule for dual-targeting toward the control of non-small cell lung cancer patient-derived xenograft tumor growthHannah Petrek, Pui Yan Ho, Neelu Batra, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|November 11, 2015
[Establishment of MDCK cell models expressing human MATE1 or co-expressing with human OCT1 or OCT2]Hong-mei Lei, Si-yuan Sun, Li-ping Li, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
The Precise Basecalling of Short-Read Nanopore SequencingZiyuan Wang, Mei-Juan Tu, Chengcheng Song, et al.
Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences|May 1, 2014
[In vitro interaction of deferiprone with cellular membrane transporters of hOCTs and hOAT1]Si-si Kong, Mei-juan Tu, Xi Yang, et al.
International Journal of Pharmaceutics|June 13, 2018
Lipidation of polyethylenimine-based polyplex increases serum stability of bioengineered RNAi agents and offers more consistent tumoral gene knockdown in vivoQian-Yu Zhang, Pui Yan Ho, Mei-Juan Tu, et al.
Molecular Therapy. Nucleic Acids|February 13, 2019
Bioengineered Let-7c Inhibits Orthotopic Hepatocellular Carcinoma and Improves Overall Survival with Minimal ImmunogenicityJoseph L Jilek, Qian-Yu Zhang, Mei-Juan Tu, et al.
Molecular Pharmacology|October 14, 2020
MicroRNA-1291-5p Sensitizes Pancreatic Carcinoma Cells to Arginine Deprivation and Chemotherapy through the Regulation of Arginolysis and GlycolysisMei-Juan Tu, Zhijian Duan, Zhenzhen Liu, et al.
Acta Pharmaceutica Sinica. B|October 6, 2023
Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancerYixin Chen, Mei-Juan Tu, Fangwei Han, et al.
Biochemical Pharmacology|November 1, 2015
Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growthYong Zhao, Mei-Juan Tu, Yi-Feng Yu, et al.
Pageof 5